Author

K. Martyniak

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

M. A. Cruz· 2 shared M. Karimzadeh· 2 shared T. J. Kean· 2 shared E. Alsberg· 1 shared O. Jeon· 1 shared R. Medam· 1 shared S. Gronowicz· 1 shared S. Kennedy· 1 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 22 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPharmacology & Toxicology

M. A. Cruz

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Disease Modifying Osteoarthritis Drug Discovery Using A Temporal Phenotypic Reporter In Primary Human Chondrocytes

M. A. Cruz, S. Gronowicz, M. Karimzadeh, K. Martyniak, R. Medam, T. J. Kean

The paper identifies aromoline as a novel drug candidate that increases type II collagen in primary human chondrocytes, with dopamine receptor D4 as a potential target for osteoarthritis treatment.

bioRxiv · Mar 10, 2023Pharmacology & Toxicology

Optimizing bioink composition for human chondrocyte expression of lubricin

K. Martyniak, S. Kennedy, M. A. Cruz, M. Karimzadeh, O. Jeon, E. Alsberg, T. J. Kean

This study identifies an optimal bioink composition for enhancing lubricin expression in human chondrocytes using a high-throughput reporter system and 3D bioprinting.

bioRxiv · Nov 14, 2022Bioengineering